Cleared Traditional

K971349 - BIOSIGN STREP A - DIRECT STREP A ANTIGEN TEST (FDA 510(k) Clearance)

Jul 1997
Decision
88d
Days
Class 1
Risk

K971349 is an FDA 510(k) clearance for the BIOSIGN STREP A - DIRECT STREP A ANTIGEN TEST. This device is classified as a Antigens, All Groups, Streptococcus Spp. (Class I - General Controls, product code GTY).

Submitted by Princeton BioMeditech Corp. (Monmouth Junction, US). The FDA issued a Cleared decision on July 7, 1997, 88 days after receiving the submission on April 10, 1997.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3740.

Submission Details

510(k) Number K971349 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 10, 1997
Decision Date July 07, 1997
Days to Decision 88 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement

Device Classification

Product Code GTY — Antigens, All Groups, Streptococcus Spp.
Device Class Class I - General Controls
CFR Regulation 21 CFR 866.3740